Additionally, existing research has determined that Trx can reverse arterial stiffness and improve endothelial function, thereby treating aged hypertensive wild-type (WT) mice and reducing blood pressure to levels comparable to young WT mice, offering a transient therapeutic effect on hypertension. The gene discussed is TXN; the disease is hypertensive disorder.